Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 15;157(4):788-799.
doi: 10.1002/ijc.35451. Epub 2025 Apr 21.

Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patients

Affiliations

Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patients

Francesca Pirini et al. Int J Cancer. .

Abstract

Lynch-like syndrome (LLS) presents very similar clinicopathological characteristics to Lynch syndrome (LS) but the mechanism for cancer predisposition remains unknown. The present study aims to investigate the causal mechanism of LLS by a comprehensive genetic and epigenetic approach. Thirty-two LLS and 34 LS patients with colorectal cancer (CRC) fitting the Amsterdam and Bethesda criteria were included, along with 29 CRC sporadic patients, and analyzed for the presence of pathogenic variants in 94 genes associated with hereditary tumors. The cohorts were also characterized for the methylation profile and examined through a sample group analysis and a Stochastic Epigenetic Mutations (SEMs) analysis in comparison with 29 age-matched healthy controls. The multigene panel analysis revealed the presence of pathogenic variants in non-mismatch repair (MMR) genes and three variants classified as pathogenic/likely pathogenic possibly predisposing to LLS. The epigenetic analysis showed epivariations targeting genes associated with LS or DNA repair, most of them associated with the Fanconi Anemia pathway, which could explain the susceptibility to cancer. Our results highlight the need for using extended genetic and epigenetic analyses to understand the causal mechanism of LLS.

Keywords: Lynch syndrome; Lynch‐like syndrome; colorectal cancer; methylation; stochastic epigenetic mutations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Scatter plots from principal component analysis (PCA) depicting the distribution of the sample cohorts across the first two principal components at the CpG site level. (B) Circos plot illustrating the genomic distribution of differentially methylated sites (red dots) across the human genome. These dots are positioned based on their –log10 (unadjusted p‐value). Notably, the X and Y‐chromosomes are excluded from the analysis.
FIGURE 2
FIGURE 2
SEMs distribution in LS, LLS and Sporadic groups. In each boxplot showing log10 transformed SEMs, the solid horizontal line within the box signifies the median of the dataset, and the box itself illustrates the interquartile range. By default, in the “ggplot” boxplot function, the whiskers stretch to data points that fall within 1.5 times the interquartile range (IQR) from the box. Individual data points beyond this range are depicted as dots, representing outliers.
FIGURE 3
FIGURE 3
(A) Venn diagrams illustrating the distribution of hypermethylated epivariations among the LS, LLS, and Sporadic groups, compared to healthy control (Refs) epivariations. (B) Venn diagrams illustrating the distribution of epivariations among the three cohorts and the prioritization of the 55 epivariations in common for LS phenotype.

References

    1. Rebuzzi F, Ulivi P, Tedaldi G. Genetic predisposition to colorectal cancer: how many and which genes to test? Int J Mol Sci. 2023;24:2137. doi: 10.3390/ijms24032137 - DOI - PMC - PubMed
    1. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology. 1999;116:1453‐1456. - PubMed
    1. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261‐268. - PMC - PubMed
    1. Hampel H, Pearlman R, Beightol M, et al. Assessment of tumor sequencing as a replacement for Lynch syndrome screening and current molecular tests for patients with colorectal cancer. JAMA Oncol. 2018;4:806‐813. doi: 10.1001/jamaoncol.2018.0104 - DOI - PMC - PubMed
    1. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851‐1860. doi: 10.1056/NEJMoa043146 - DOI - PubMed

LinkOut - more resources